Science | Nature | Cell | View More
Natural Products
Aloesin
Aloesin
ChemFaces products have been cited in many studies from excellent and top scientific journals
Product Name Aloesin
Price:
CAS No.: 30861-27-9
Catalog No.: CFN91659
Molecular Formula: C19H22O9
Molecular Weight: 394.37 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Powder
Source: The herbs of Aloe arborescens Mill.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Download: COA    MSDS
Similar structural: Comparison (Web)  (SDF)
Guestbook:
Contact Us
Order & Inquiry & Tech Support

Tel: (0086)-27-84237683
Tech: service@chemfaces.com
Order: manager@chemfaces.com
Address: 176, CheCheng Eest Rd., WETDZ, Wuhan, Hubei 430056, PRC
How to Order
Orders via your E-mail:

1. Product number / Name / CAS No.
2. Delivery address
3. Ordering/billing address
4. Contact information
Order: manager@chemfaces.com
Delivery time
Delivery & Payment method

1. Usually delivery time: Next day delivery by 9:00 a.m. Order now

2. We accept: Wire transfer & Credit card & Paypal
Citing Use of our Products
* Packaging according to customer requirements(5mg, 10mg, 20mg and more). We shipped via FedEx, DHL, UPS, EMS and others courier.
According to end customer requirements, ChemFaces provide solvent format. This solvent format of product intended use: Signaling Inhibitors, Biological activities or Pharmacological activities.
Size /Price /Stock 10 mM * 1 mL in DMSO / Inquiry
Other Packaging *Packaging according to customer requirements(100uL/well, 200uL/well and more), and Container use Storage Tube With Screw Cap
Our products had been exported to the following research institutions and universities, And still growing.
  • The Institute of Cancer Research (United Kingdom)
  • Cancer Research Initatives Foun... (Malaysia)
  • Universiti Kebangsaan Malaysia (Malaysia)
  • Deutsches Krebsforschungszentrum (Germany)
  • Max Rubner-Institut (MRI) (Germany)
  • Universidade Federal de Santa C... (Brazil)
  • Guangzhou Institutes of Biomedi... (China)
  • Universidade Católica Portuguesa (Portugal)
  • Nicolaus Copernicus Uniwersity (Poland)
  • The Vancouver Prostate Centre (... (Canada)
  • Universita' Degli Studi Di Cagl... (Italy)
  • More...
Package
Featured Products
Isobutylshikonin

Catalog No: CFN92023
CAS No: 52438-12-7
Price: $268/10mg
Ardisiacrispin A

Catalog No: CFN90177
CAS No: 23643-61-0
Price: $268/5mg
5-O-Feruloylquinic acid

Catalog No: CFN92889
CAS No: 40242-06-6
Price: $318/10mg
Lasiocarpine

Catalog No: CFN00289
CAS No: 303-34-4
Price: $ /
Vitexin 2''-glucoside

Catalog No: CFN70421
CAS No: 61360-94-9
Price: $ / mg
Terpineol

Catalog No: CFN92688
CAS No: 98-55-5
Price: $30/20mg
Pinocembrin

Catalog No: CFN98740
CAS No: 480-39-7
Price: $40/20mg
Ascorbic acid

Catalog No: CFN90048
CAS No: 50-81-7
Price: $30/20mg
Maackiain

Catalog No: CFN99746
CAS No: 19908-48-6
Price: $100/20mg
Caftaric acid

Catalog No: CFN00384
CAS No: 67879-58-7
Price: $138/20mg
Related Screening Libraries
Size /Price /Stock 10 mM * 100 uL in DMSO / Inquiry / In-stock
10 mM * 1 mL in DMSO / Inquiry / In-stock
Related Libraries
Biological Activity
Description: Aloesin (Aloeresin) is an active constituent of the herb aloe vera and displays anti-inflammatory activity, ultraviolet protection, inhibits tyrosinase (IC50 = 0.9 mM)activity and antibacterium effects. Aloesin exerts its anticancer effect through the MAPK signaling pathway
In vitro:
Anal Cell Pathol (Amst) . 2017;2017:8158254.
Aloesin Suppresses Cell Growth and Metastasis in Ovarian Cancer SKOV3 Cells through the Inhibition of the MAPK Signaling Pathway[Pubmed: 28702312]
Aloesin is an active constituent of the herb aloe vera and plays a crucial role in anti-inflammatory activity, ultraviolet protection, and antibacterium. We investigated the role and possible mechanisms of Aloesin in the cell growth and metastasis of ovarian cancer. It was found that Aloesin inhibited cell viability and cell clonality in a dose-dependent manner. It arrests the cell cycle at the S-phase and induced apoptosis in SKOV3 cells. In an in vivo experiment, it was observed that Aloesin inhibited tumor growth. Moreover, it inhibited migration and invasion of cancer in SKOV3 cells. Interestingly, members from the mitogen-activated protein kinase (MAPK) signaling family became less phosphorylated as the Aloesin dose increased. This suggests that Aloesin exerts its anticancer effect through the MAPK signaling pathway. Our data also highlights the possibility of using Aloesin as a novel therapeutic drug for ovarian cancer treatment.
Phytomedicine . 2017 May 15;28:19-26.
Aloesin from Aloe vera accelerates skin wound healing by modulating MAPK/Rho and Smad signaling pathways in vitro and in vivo[Pubmed: 28478809]
Background: Cutaneous wound healing is a complex process involving various regulatory factors at the molecular level. Aloe vera is widely used for cell rejuvenation, wound healing, and skin moisturizing. Hypothesis/purpose: This study aimed to investigate the effects of Aloesin from Aloe vera on cutaneous wound healing and mechanisms involved therein. Study design: This study consisted of both in vitro and in vivo experiments involving skin cell lines and mouse model to demonstrate the wound healing effects of Aloesin by taking into account several parameters ranging from cultured cell migration to wound healing in mice. Methods: The activities of Smad signaling molecules (Smad2 and Smad3), MAPKs (ERK and JNK), and migration-related proteins (Cdc42, Rac1, and α-Pak) were assessed after Aloesin treatment in cultured cells (1, 5 and 10μM) and mouse skin (0.1% and 0.5%). We also monitored macrophage recruitment, secretion of cytokines and growth factors, tissue development, and angiogenesis after Aloesin treatment using IHC analysis and ELISAs. Results: Aloesin increased cell migration via phosphorylation of Cdc42 and Rac1. Aloesin positively regulated the release of cytokines and growth factors (IL-1β, IL-6, TGF-β1 and TNF-α) from macrophages (RAW264.7) and enhanced angiogenesis in endothelial cells (HUVECs). Aloesin treatment accelerated wound closure rates in hairless mice by inducing angiogenesis, collagen deposition and granulation tissue formation. More importantly, Aloesin treatment resulted in the activation of Smad and MAPK signaling proteins that are key players in cell migration, angiogenesis and tissue development. Conclusion: Aloesin ameliorates each phase of the wound healing process including inflammation, proliferation and remodeling through MAPK/Rho and Smad signaling pathways. These findings indicate that Aloesin has the therapeutic potential for treating cutaneous wounds.
Clin Exp Dermatol . 2002 Sep;27(6):513-515.
Aloesin inhibits hyperpigmentation induced by UV radiation[Pubmed: 12372097]
Skin hyperpigmentation is caused by the overproduction of melanin pigment, which is synthesized by the action of tyrosinase. We recently reported that Aloesin inhibits tyrosinase activity. The present study was undertaken to test the inhibitory effect of Aloesin on pigmentation in human skin after UV radiation. Experimental subjects were UV-irradiated (210 mJ) on the inner forearm. UV-irradiated regions were assigned to four groups: vehicle control, Aloesin treated, arbutin treated, and Aloesin and arbutin treated. Aloesin and/or arbutin were administered four times a day for 15 days. Aloesin treatment suppressed pigmentation by 34%, arbutin by 43.5%, and the cotreatment by 63.3% compared with the control (n = 15; P < 0.05). Moreover, Aloesin treatment showed pigmentation suppression in a dose-dependent manner (n = 7; P < 0.05). These results raise the possibility that Aloesin may be used as an agent that inhibits melanin formation induced by UV radiation.
Regul Toxicol Pharmacol . 2011 Nov;61(2):215-221.
In vitro and in vivo assessment of the genotoxic activity of aloesin[Pubmed: 21821088]
Aloesin is a chromone that is a component of Aloe spp. It may have potential as a functional food ingredient as it has been shown to likely have beneficial effects in persons in a pre-diabetic state or who have metabolic syndrome. In this study the safety of Aloesin has been evaluated using a series of in vitro and in vivo genotoxicity assays including, bacterial mutation, mammalian cell cytogenetic, and mouse micronucleus tests. Aloesin did not induce reverse mutations in Salmonella typhimurium and Escherichia coli at any of the tested dose levels up to 10,000 μg/plate. Similarly, Aloesin did not increase the incidence of chromosome aberrations when incubated with Chinese hamster lung cells at any of the tested concentrations up to 10,000 μg/mL. In vivo, there was no effect of Aloesin on the incidence of micronucleated erythrocytes following oral administration on two consecutive days at doses up to 5000 mg/kg body weight. There was no evidence of toxicity to bone marrow. The results of these studies demonstrate that Aloesin is without genotoxic potential.
Biochem Mol Biol Int . 1997 Feb;41(2):285-292.
Aloesin up-regulates cyclin E/CDK2 kinase activity via inducing the protein levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells[Pubmed: 9063568]
In the present study, we show that Aloesin, which is a low molecular weight ingredients present in Aloe vera, stimulates the proliferation of cultured human hepatoma SK-HEP-1 cells. The incorporation of [3H] thymidine into DNA in the cell cultures was significantly increased at a dose of 10 microM Aloesin. The Aloesin-induced DNA synthesis appears to require newly synthesized proteins because cycloheximide treatment blocked the DNA synthesis evoked by this compound. We then examined whether this compound increases the intracellular levels of cell cycle regulators by immunoblotting. The data showed that Aloesin increased the levels of cyclin E, CDK2, and CDC25A in SK-HEP-1 cells. In addition, immuno-complex kinase assays showed that Aloesin up-regulated the enzyme activity of cyclin E/CDK2 kinase in a dose-dependent manner. Collectively, these results suggest that Aloesin stimulates the proliferation of SK-HEP-1 cells by inducing the intracellular levels of cyclin E/CDK2 kinase complex and CDC25A, which, together, result in the up-regulation of cyclin E-dependent kinase activity.
Fitoterapia . 2021 Apr;150:104828.
Anti-tyrosinase activity of South African Aloe species and isolated compounds plicataloside and aloesin[Pubmed: 33434632]
Tyrosinase is the key enzyme in the production of melanin. Tyrosinase inhibitors have gained interest in the cosmetics industry to prevent hyperpigmentation and skin-related disorders by inhibiting melanin production. It has been reported that several Aloe species exhibit anti-tyrosinase efficacy in vitro. In this study, the exudates of thirty-nine South African Aloe species were screened to identify species and compounds with anti-tyrosinase activity. Qualitative screening revealed that twenty-nine Aloe species exhibited tyrosinase inhibition activity with one to three active bands. Quantitative screening was performed for 29 species and expressed as IC50 values. Three species were further analysed and subsequently, Aloesin and aloeresin A was isolated from A. ferox and plicataloside from A. plicatilis and A. chabaudii. Aloeresin A was determined to be a substrate of mushroom tyrosinase. Dose-response assays showed that Aloesin (IC50 = 31.5 μM) and plicataloside (IC50 = 84.1 μM) exhibited moderate to weak activity. Molecular docking scores for plicataloside were considerably lower than for Aloesin (P < 0.01), confirming its lower IC50. Several Aloe species may have potential for the management of hyperpigmentation or as a skin lightening agent. This is the first report showing that plicataloside, present in A. plicatilis and A. chabaudii, exhibits anti-tyrosinase activity.
In vivo:
Phytomedicine . 2017 May 15;28:19-26.
Aloesin from Aloe vera accelerates skin wound healing by modulating MAPK/Rho and Smad signaling pathways in vitro and in vivo[Pubmed: 28478809]
Background: Cutaneous wound healing is a complex process involving various regulatory factors at the molecular level. Aloe vera is widely used for cell rejuvenation, wound healing, and skin moisturizing. Hypothesis/purpose: This study aimed to investigate the effects of Aloesin from Aloe vera on cutaneous wound healing and mechanisms involved therein. Study design: This study consisted of both in vitro and in vivo experiments involving skin cell lines and mouse model to demonstrate the wound healing effects of Aloesin by taking into account several parameters ranging from cultured cell migration to wound healing in mice. Methods: The activities of Smad signaling molecules (Smad2 and Smad3), MAPKs (ERK and JNK), and migration-related proteins (Cdc42, Rac1, and α-Pak) were assessed after Aloesin treatment in cultured cells (1, 5 and 10μM) and mouse skin (0.1% and 0.5%). We also monitored macrophage recruitment, secretion of cytokines and growth factors, tissue development, and angiogenesis after Aloesin treatment using IHC analysis and ELISAs. Results: Aloesin increased cell migration via phosphorylation of Cdc42 and Rac1. Aloesin positively regulated the release of cytokines and growth factors (IL-1β, IL-6, TGF-β1 and TNF-α) from macrophages (RAW264.7) and enhanced angiogenesis in endothelial cells (HUVECs). Aloesin treatment accelerated wound closure rates in hairless mice by inducing angiogenesis, collagen deposition and granulation tissue formation. More importantly, Aloesin treatment resulted in the activation of Smad and MAPK signaling proteins that are key players in cell migration, angiogenesis and tissue development. Conclusion: Aloesin ameliorates each phase of the wound healing process including inflammation, proliferation and remodeling through MAPK/Rho and Smad signaling pathways. These findings indicate that Aloesin has the therapeutic potential for treating cutaneous wounds.
Regul Toxicol Pharmacol . 2011 Nov;61(2):215-221.
In vitro and in vivo assessment of the genotoxic activity of aloesin[Pubmed: 21821088]
Aloesin is a chromone that is a component of Aloe spp. It may have potential as a functional food ingredient as it has been shown to likely have beneficial effects in persons in a pre-diabetic state or who have metabolic syndrome. In this study the safety of Aloesin has been evaluated using a series of in vitro and in vivo genotoxicity assays including, bacterial mutation, mammalian cell cytogenetic, and mouse micronucleus tests. Aloesin did not induce reverse mutations in Salmonella typhimurium and Escherichia coli at any of the tested dose levels up to 10,000 μg/plate. Similarly, Aloesin did not increase the incidence of chromosome aberrations when incubated with Chinese hamster lung cells at any of the tested concentrations up to 10,000 μg/mL. In vivo, there was no effect of Aloesin on the incidence of micronucleated erythrocytes following oral administration on two consecutive days at doses up to 5000 mg/kg body weight. There was no evidence of toxicity to bone marrow. The results of these studies demonstrate that Aloesin is without genotoxic potential.
Aloesin Description
Source: The herbs of Aloe arborescens Mill.
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Storage: Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

After receiving: The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
ChemFaces New Products and Compounds
Hosenkoside D

Catalog No: CFN95521
CAS No: 156823-94-8
Price: $318/5mg
Kidjolanin

Catalog No: CFN95503
CAS No: 38395-01-6
Price: $318/5mg
Benzyl beta-D-glucopyranoside

Catalog No: CFN95427
CAS No: 4304-12-5
Price: $318/10mg
Rosmarinyl glucoside

Catalog No: CFN95297
CAS No: 910028-78-3
Price: $413/5mg
12beta-Acetoxy-3beta-hydroxy-7,11,...

Catalog No: CFN95468
CAS No: 1085338-75-5
Price: $318/5mg
Oxytroflavoside A

Catalog No: CFN95463
CAS No: 1391144-80-1
Price: $318/5mg
Glyasperin C

Catalog No: CFN95065
CAS No: 142474-53-1
Price: $333/5mg
Polygalasaponin XXXV

Catalog No: CFN95176
CAS No: 184479-28-5
Price: $463/5mg
Recently, ChemFaces products have been cited in many studies from excellent and top scientific journals

Cell. 2018 Jan 11;172(1-2):249-261.e12.
doi: 10.1016/j.cell.2017.12.019.
IF=36.216(2019)

PMID: 29328914

Cell Metab. 2020 Mar 3;31(3):534-548.e5.
doi: 10.1016/j.cmet.2020.01.002.
IF=22.415(2019)

PMID: 32004475

Mol Cell. 2017 Nov 16;68(4):673-685.e6.
doi: 10.1016/j.molcel.2017.10.022.
IF=14.548(2019)

PMID: 29149595

ACS Nano. 2018 Apr 24;12(4): 3385-3396.
doi: 10.1021/acsnano.7b08969.
IF=13.903(2019)

PMID: 29553709

Nature Plants. 2016 Dec 22;3: 16206.
doi: 10.1038/nplants.2016.205.
IF=13.297(2019)

PMID: 28005066

Sci Adv. 2018 Oct 24;4(10): eaat6994.
doi: 10.1126/sciadv.aat6994.
IF=12.804(2019)

PMID: 30417089
Calculate Dilution Ratios(Only for Reference)
1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.5357 mL 12.6784 mL 25.3569 mL 50.7138 mL 63.3922 mL
5 mM 0.5071 mL 2.5357 mL 5.0714 mL 10.1428 mL 12.6784 mL
10 mM 0.2536 mL 1.2678 mL 2.5357 mL 5.0714 mL 6.3392 mL
50 mM 0.0507 mL 0.2536 mL 0.5071 mL 1.0143 mL 1.2678 mL
100 mM 0.0254 mL 0.1268 mL 0.2536 mL 0.5071 mL 0.6339 mL
* Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
Isobutylshikonin

Catalog No: CFN92023
CAS No: 52438-12-7
Price: $268/10mg
Ardisiacrispin A

Catalog No: CFN90177
CAS No: 23643-61-0
Price: $268/5mg
5-O-Feruloylquinic acid

Catalog No: CFN92889
CAS No: 40242-06-6
Price: $318/10mg
Lasiocarpine

Catalog No: CFN00289
CAS No: 303-34-4
Price: $ /
Vitexin 2''-glucoside

Catalog No: CFN70421
CAS No: 61360-94-9
Price: $ / mg
Terpineol

Catalog No: CFN92688
CAS No: 98-55-5
Price: $30/20mg
Pinocembrin

Catalog No: CFN98740
CAS No: 480-39-7
Price: $40/20mg
Ascorbic acid

Catalog No: CFN90048
CAS No: 50-81-7
Price: $30/20mg
Maackiain

Catalog No: CFN99746
CAS No: 19908-48-6
Price: $100/20mg
Caftaric acid

Catalog No: CFN00384
CAS No: 67879-58-7
Price: $138/20mg
Tags: buy Aloesin | Aloesin supplier | purchase Aloesin | Aloesin cost | Aloesin manufacturer | order Aloesin | Aloesin distributor